-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On October 13, 2021, Ingevity announced that it will increase caprolactone monomer production capacity at its Warrington, UK plant through a series of optimization projects over the next 12 months, which is expected to increase Ingevity's global caprolactone production capacity.
Monolithic capacity increased by more than 20%, enabling the company to better meet demand and serve customers more efficiently
.
"Customer demand for high-performance, sustainable solutions in our Capa® portfolio of engineered polymers continues to grow," said Mike Smith, executive vice president and head of the company's Performance Chemicals business
.
"We are committed to continuing to invest in innovation, production This exciting news follows
the company’s recent announcement that it will open a new innovation center in Warrington by the end of 2021, Smith added.
And add polyol production capacity at its DeRidder, Louisiana facility in the second quarter of 2022
.
"This capacity expansion in Warrington will allow Ingevity to better meet the growing global demand for our Capa® derived technology and improve the reliability of monomer supply in the commercial market," said Steve Hulme, vice president of Ingevity's engineered polymers business.
, and strengthen service to customers around the world
.
”